Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food

NCT02852876 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Genitalis
Herpes Zoster

Interventions

DRUG: ASP2151
DRUG: Placebo

Sponsor

Astellas Pharma Europe Ltd.